Connect with us

Hi, what are you looking for?

Health

NAFDAC Recalls Benylin, Children’s Cough Syrup over Toxic Substance

Benylin Paediatrics Syrup

National Agency for Food and Drugs Administration and Control (NAFDAC), has recalled a batch of a cough syrup brand manufactured by Johnson & Johnson, following toxicity findings.

The product named Benylin Paediatrics Syrup was found to be contaminated with an unacceptably high level of diethylene glycol, a toxic substance that can lead to acute kidney injury and even death, the agency said.

High levels of diethylene glycol and/or a related chemical called ethylene glycol have previously been implicated in a recent wave of poisoning cases involving India-made cough syrups.

The affected Benylin Paediatrics Syrup batch, manufactured by Johnson & Johnson in South Africa, was due to expire in April NAFDAC noted.

The regulator called for an immediate end to its sales or use and urged the public to return the stock to the nearest NAFDAC office.

Benylin Paediatric syrup is indicated for children aged 2 to 12 years to treat conditions such as coughs and allergic conditions, including hay fever.

Loading

Spread the love
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

NCC
ad

You May Also Like

News

Independent Corrupt Practices and Other Related Offences Commission (ICPC), the Economic and Financial Crimes Commission (EFCC), and the Federal Competition and Consumer Protection Commission...

E-health

RaveNewsOnline reports that  the National Agency for Food and Drug Administration and Control (NAFDAC) on Thursday, October 22, uncovered another illegal herbal products factory...

News

The National Agency for Food, Drug, Administration and Control NAFDAC, has uncovered an illegal herbal product manufacturing facility in Agege, Lagos State, following a...

News

Former Vice President and presidential candidate of the African Democratic Congress (ADC), Atiku Abubakar, has demanded the immediate publication of Nigeria’s health agreement with...